Su questa pagina
01CSBR prezzo
02Snapshot
03Grafico
04Split azionari
05Chi siamo
06Performance
07Valutazione e rapporti
14Utili
15Fondamentali Completi
16Bilanci
17Proprietari istituzionali (13F)
18Attivisti e proprietari del 5%+
19Insider aziendali
20Proprietà ETF
21Consenso
22Peer
25Segnali di trading
26Le Mie Metriche
CSBR Champions Oncology, Inc. - Common Stock
NASDAQ · Life Sciences Tools & Services · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Set 11, 2026
$4,94
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$4,59minimo 52 sett.
$8,31massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$69M
P/E
-61.8
EPS
$-0.08
Ricavi
$59M
i tuoi badge
Intervallo 52 sett.
$5–$8
Rating Analisti
BUY
Prezzo Obiettivo
·
P/E
-61.8
ROE
-30.5%
Margine di Profitto Netto
-1.9%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
CSBR Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$4.94
Capitalizzazione di Mercato (MRQ)
$69M
P/E
-61.8
EPS
$-0.08
Ricavi
$59M
ROE
-30.5%
Intervallo 52 sett.
$5–$8
CSBR Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 12 Agosto 2015 | 1-for-12 | Inverso |
Informazioni su Champions Oncology, Inc. - Common Stock Panoramica della società da Wikipedia
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist.
TumorGrafts
Champions TumorGrafts maintain the microenvironment surrounding the tumor and have been shown to have high correlation to the patient’s tumor. Due to this close resemblance to the human tumor, TumorGrafts are highly predictive of treatment outcomes in patients. Studies have shown the mouse avatars predict clinical benefit in 80% of patients. Approximately 450 TumorGrafts have been established as of April 2014.
TumorGrafts are also being used as a pre-clinical research tool to improve clinical drug development. Compared to traditional xenograft models, TumorGrafts, have a greater degree of accuracy in predicting clinical effectiveness of oncology drugs and thus can decrease clinical risk for drug developers. Champions has formed partnerships with multiple drug developers, including Teva and Pfizer.
The process
When a cancer patient undergoes surgery or biopsy, a living sample of the tumor is obtained and implanted into the mouse, creating a mouse avatar. Once the TumorGraft has successfully grown, the tumor is then propagated in a second generation of mice and tested against a panel of cancer drugs and drug combinations to help identify more accurately which treatment regimen is likely to be most effective in a specific patient. In this way, various drugs are tested on a live sample of the actual patient's tumor, rather than on the patient. This reduces the likelihood of treatment with ineffective drugs and their associated side effects, and it increases the likelihood of finding a treatment that will work against the patient's tumor. For patients whose tumors have also undergone molecular testing, such as next-generation sequencing, the selection of potential drugs is further guided by any and all applicable results. In the event the cancer progresses or recurs, Champions also banks, or stores, each successful TumorGraft for potential future patient use.
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
settoreHealthcare
industriaLife Sciences Tools & Services
dipendenti214
paeseUS
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$59M2018-04-30 → 2026-04-30
EPS$-0.082018-04-30 → 2026-04-30
Flusso di cassa libero$-5M2017-04-30 → 2026-04-30
Margine netto-1.9%2019-04-30 → 2026-04-30
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | CSBR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -61.8media 5 anni ≈23.5 | ≈23.5 | · | · | |
| P/S (TTM) | 1.1media 5 anni ≈1.6 | ≈1.6 | 2.7 | Sottovalutato | |
| P/B (MRQ) | 17.7media 5 anni ≈7.7 | ≈7.7 | 1.8 | Sopravvalutato | |
| Prezzo / FCF (TTM) | -11.2media 5 anni ≈14.8 | ≈14.8 | · | · | |
| Prezzo / Flusso di cassa (TTM) | -12.4media 5 anni ≈3.4 | ≈3.4 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 19.0media 5 anni ≈19.7 | ≈19.7 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | CSBR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | -1.7%media 5 anni ≈-3.4% | ≈-3.4% | -108.0% | Di prim'ordine | |
| Margine EBITDA (TTM) | 0.55%media 5 anni ≈-0.32% | ≈-0.32% | -108.0% | Di prim'ordine | |
| Margine ante imposte (TTM) | -1.5%media 5 anni ≈-3.3% | ≈-3.3% | -100.0% | Di prim'ordine | |
| Margine di Profitto Netto (TTM) | -1.9%media 5 anni ≈-3.4% | ≈-3.4% | -105.8% | Di prim'ordine | |
| ROA | -4.0%media 5 anni ≈-5.1% | ≈-5.1% | -26.0% | Di prim'ordine | |
| ROE | -30.5%media 5 anni ≈92.6% | ≈92.6% | -34.9% | In linea | |
| ROIC | -36.6%media 5 anni ≈72.5% | ≈72.5% | -38.6% | In linea |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | CSBR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 1.0media 5 anni ≈0.9 | ≈0.9 | 2.9 | Bassa liquidità | |
| Quick Ratio | 0.9media 5 anni ≈0.8 | ≈0.8 | 1.4 | Bassa liquidità |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | CSBR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 4.4%media 5 anni ≈8.1% | ≈8.1% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 3.3%media 5 anni ≈8.5% | ≈8.5% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 7.7% | · | · | · | |
| EPS CAGR 3Y (CAGR EPS 3 anni) | 102.1% | · | · | · | |
| Net Income CAGR 3Y (CAGR Utile Netto 3 anni) | 104.7% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | CSBR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 2.0media 5 anni ≈1.7 | ≈1.7 | 0.4 | Di prim'ordine | |
| Receivables Turnover (Rotazione dei crediti) | 4.9media 5 anni ≈5.7 | ≈5.7 | 5.0 | In linea | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$277.7K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-7.2%
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 31 Marzo 2027 | Set 10, 2026 | $-0.03 | $-0.01 | -194.1% |
| 30 Settembre 2026 | $-0.03 | $-0.01 | -194.1% | |
| 30 Giugno 2026 | $-0.05 | $-0.05 | 2.0% | |
| 31 Marzo 2026 | $-0.02 | $0.09 | -121.8% | |
| 31 Dicembre 2025 | $0.02 | $0.01 | 96.1% | |
| 30 Settembre 2025 | $0.02 | $-0.01 | 296.1% | |
| 30 Giugno 2025 | $-0.07 | $-0.20 | 65.7% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $59M | $57M | $50M | $54M | $49M | $41M | $32M | $3M | $20M | |
| Cost of Revenue | $31M | $28M | $29M | $30M | $24M | $21M | $17M | · | · | |
| R&D Expense | $9M | $7M | $10M | $12M | $9M | $7M | $6M | $5M | $4M | |
| SG&A Expense | $11M | $9M | $11M | $10M | $9M | $7M | $7M | $5M | $4M | |
| Operating Expenses | · | · | · | · | · | · | $34M | $27M | $22M | |
| Operating Income | $-1M | $5M | $-7M | $-5M | $607.0K | $366.0K | $-2M | $270.0K | $-1M | |
| Other Non-op | $211.0K | $73.0K | $48.0K | $-11.0K | $-24.0K | $71.0K | $-42.0K | $-39.0K | $-89.0K | |
| Pretax Income | $-929.0K | $5M | $-7M | $-5M | $583.0K | $437.0K | $-2M | $231.0K | $-1M | |
| Income Tax | $246.0K | $-75.0K | $-32.0K | $68.0K | $35.0K | $75.0K | $130.0K | $103.0K | $33.0K | |
| Net Income | $-1M | $5M | $-7M | $-5M | $548.0K | $362.0K | $-2M | $128.0K | $-1M | |
| EPS (Basic) | $-0.08 | $0.34 | $-0.54 | $-0.39 | $0.04 | $0.03 | $-0.18 | $0.01 | $-0.13 | |
| EPS (Diluted) | $-0.08 | $0.33 | $-0.54 | $-0.39 | $0.04 | $0.02 | $-0.18 | $0.01 | $-0.13 | |
| Shares (Basic) | 13,832,385 | 13,659,786 | 13,547,604 | 13,541,559 | 13,197,170 | 13,138,995 | 11,843,463 | 11,340,184 | 10,991,105 | |
| Shares (Diluted) | 13,832,385 | 14,266,781 | 13,547,604 | 13,541,559 | 14,159,799 | 14,573,561 | 11,843,463 | 14,096,117 | 10,991,105 | |
| EBITDA | $260.0K | $6M | $-6M | $-3M | $2M | $2M | $-978.0K | $876.0K | $-994.0K |
Stato Patrimoniale
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $10M | $3M | $10M | $9M | $5M | $8M | $3M | $856.0K | |
| Receivables | $13M | $11M | $10M | $8M | $10M | $7M | $5M | $4M | $4M | |
| Prepaid Expense | $1M | $1M | $1M | $1M | $1M | $957.0K | $385.0K | $308.0K | $287.0K | |
| Current Assets | $19M | $22M | $14M | $19M | $20M | $13M | $13M | $8M | $5M | |
| PP&E (Net) | · | · | · | · | $7M | $6M | $4M | $3M | $2M | |
| PP&E (Gross) | $16M | $16M | $16M | $16M | $13M | $10M | $7M | $5M | $4M | |
| Accum. Depreciation | $13M | $12M | $10M | $9M | $6M | $4M | $3M | $2M | $1M | |
| Goodwill | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $670.0K | $669.0K | |
| Other Non-current Assets | $212.0K | $196.0K | $185.0K | $15.0K | $15.0K | $15.0K | $128.0K | $128.0K | $116.0K | |
| Total Assets | $27M | $32M | $26M | $34M | $35M | $28M | $21M | $11M | $8M | |
| Accounts Payable | $7M | $4M | $6M | $5M | $3M | $2M | $3M | $3M | $2M | |
| Accrued Liabilities | $3M | $3M | $2M | $2M | $2M | $2M | $3M | $1M | $569.0K | |
| Current Liabilities | $20M | $24M | $22M | $22M | $17M | $11M | $12M | $8M | $7M | |
| Capital Leases | $3M | $5M | $6M | $7M | $8M | $9M | $3M | $0 | $17.0K | |
| Other Non-current Liabilities | $7.0K | $85.0K | $401.0K | $551.0K | $391.0K | $181.0K | $178.0K | $151.0K | $151.0K | |
| Total Liabilities | $23M | $29M | $28M | $30M | $26M | $20M | $16M | $9M | $8M | |
| Common Stock | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $13.0K | $13.0K | $12.0K | $11.0K | |
| Retained Earnings | $-81M | $-80M | $-85M | $-77M | $-72M | $-73M | $-73M | $-71M | $-71M | |
| Treasury Stock | $708.0K | $708.0K | $708.0K | $74.0K | $0 | · | · | $0 | $1M | |
| Stockholders' Equity | $4M | $4M | $-2M | $5M | $9M | $7M | $5M | $2M | $3.0K | |
| Liabilities + Equity | $27M | $32M | $26M | $34M | $35M | $28M | $21M | $11M | $8M | |
| Shares Outstanding | 13,886,826 | 13,897,503 | 13,714,099 | 13,558,650 | 13,522,441 | 13,414,066 | 12,726,728 | 11,619,538 | 11,003,228 |
Flusso di cassa
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $2M | $2M | $2M | $2M | $925.0K | $825.0K | $606.0K | $360.0K | |
| Stock-based Comp | $1M | $654.0K | $1M | $864.0K | $912.0K | $598.0K | $600.0K | $636.0K | $1M | |
| Deferred Tax | $0 | $0 | · | · | · | · | · | · | · | |
| Other Non-cash | $-6M | $431.0K | $-2M | $6M | $4M | $-4M | $3M | $492.0K | $-1M | |
| Operating Cash Flow | $-4M | $7M | $-6M | $4M | $6M | $-2M | $3M | $2M | $-1M | |
| CapEx | $564.0K | $389.0K | $836.0K | $3M | $2M | $3M | $2M | $834.0K | $1M | |
| Investing Cash Flow | $-540.0K | $-389.0K | $-836.0K | $-3M | $-2M | $-3M | $-2M | $-834.0K | $-1M | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | |
| Stock Repurchased | · | $0 | $634.0K | $74.0K | $0 | · | · | · | · | |
| Net Stock Activity | · | $0 | $-634.0K | $-74.0K | · | · | · | · | $0 | |
| Financing Cash Flow | $99.0K | $170.0K | $-527.0K | $11.0K | $207.0K | $1M | $4M | $1M | $13.0K | |
| Net Change in Cash | $-5M | $7M | $-8M | $1M | $4M | $-4M | $5M | $2M | $-2M | |
| Taxes Paid | $242.0K | $43.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | $-5M | $7M | $-7M | $1M | $4M | $-5M | $685.0K | $1M | $-2M |
Redditività
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1.9% | 8.0% | -14.7% | -9.8% | 1.2% | 0.89% | · | 1.0% | · | |
| Net Margin | -2.0% | 8.3% | -14.5% | -9.9% | 1.1% | 0.88% | · | 0.47% | · | |
| Pretax Margin | -1.6% | 8.1% | -14.6% | -9.8% | 1.2% | 1.1% | · | 0.85% | · | |
| EBITDA Margin | 0.44% | 10.8% | -11.3% | -5.9% | 4.3% | 3.8% | · | 3.2% | · | |
| ROA | -4.0% | 16.1% | -24.1% | -15.3% | 1.7% | 1.5% | -12.5% | 1.3% | -18.6% | |
| ROE | -30.5% | 211.1% | 367.4% | -91.2% | 6.0% | 4.7% | -36.9% | 5.6% | -744.4% | |
| ROIC | -36.6% | 122.7% | 384.9% | -114.8% | 6.3% | 4.1% | -36.3% | 6.7% | -46165.5% |
Liquidità e Solvibilità
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 0.9 | 0.6 | 0.9 | 1.1 | 1.1 | 1.1 | 1.0 | 0.7 | |
| Quick Ratio | 0.9 | 0.9 | 0.6 | 0.8 | 1.1 | 1.0 | 1.1 | 0.9 | 0.6 |
Efficienza
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.0 | 1.9 | 1.7 | 1.5 | 1.6 | 1.7 | · | 2.8 | · | |
| Receivables Turnover | 4.9 | 5.5 | 5.8 | 6.3 | 6.0 | 7.0 | · | 6.5 | · |
Per Azione
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.28 | $0.27 | $-0.14 | $0.34 | $0.67 | $0.55 | $0.42 | $0.19 | $0.00 | |
| Revenue / Share | $4.30 | $3.99 | $3.70 | $3.98 | $3.47 | $2.82 | · | $1.92 | · | |
| Cash Flow / Share | $-0.32 | $0.52 | $-0.45 | $0.29 | $0.46 | $-0.12 | $0.25 | $0.13 | · | |
| Cash / Share | $0.35 | $0.71 | $0.19 | $0.75 | $0.67 | $0.35 | $0.65 | $0.28 | $0.08 | |
| EPS (TTM) | $-0.08 | $0.33 | $-0.54 | $-0.39 | $0.04 | $0.02 | $-0.18 | $0.01 | $-0.13 |
Tassi di Crescita
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.4% | 13.5% | -6.9% | 9.7% | 19.7% | 27.8% | · | · | · | |
| Revenue CAGR 3Y | 3.3% | 5.1% | 6.9% | 18.8% | · | · | · | · | · | |
| Revenue CAGR 5Y | 7.7% | 12.1% | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | 100.0% | · | · | · | · | |
| EPS CAGR 3Y | · | 102.1% | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | 51.4% | · | · | · | · | |
| Net Income CAGR 3Y | · | 104.7% | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $59M | $57M | $50M | $54M | $49M | $41M | $32M | $3M | $20M | |
| Net Income TTM | $-1M | $5M | $-7M | $-5M | $548.0K | $362.0K | $-2M | $128.0K | $-1M | |
| Market Cap | $83M | $99M | $66M | $67M | $104M | $144M | $98M | $106M | $48M | |
| P/E | -74.5 | 21.7 | -9.0 | -12.6 | 192.0 | 536.5 | -42.9 | 908.0 | -33.4 | |
| P/S | 1.4 | 1.7 | 1.3 | 1.2 | 2.1 | 3.5 | 3.1 | 36.4 | 2.4 | |
| P/B | 21.0 | 26.1 | -34.6 | 14.4 | 11.4 | 19.4 | 18.5 | 47.1 | 15918.0 | |
| P / Tangible Book | 23.0 | 28.7 | · | 15.5 | 11.9 | 20.3 | 20.6 | · | · | |
| P / Cash Flow | -18.5 | 13.3 | -10.7 | 16.8 | 16.0 | -85.6 | 33.8 | 56.7 | -39.0 | |
| P / FCF | -16.4 | 14.1 | -9.4 | 60.6 | 25.2 | -29.0 | 143.4 | 102.6 | -19.5 | |
| Earnings Yield | -1.3% | 4.6% | -11.1% | -7.9% | 0.52% | 0.19% | -2.3% | 0.11% | -3.0% |
Conto Economico
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15M | $14M | $17M | $15M | $14M | $12M | $17M | $13M | $14M | $14M | $12M | $12M | $13M | $13M | $13M | $14M | |
| Cost of Revenue | $8M | $7M | $9M | $7M | $8M | $7M | $7M | $7M | $7M | $7M | $8M | $7M | $8M | $7M | $8M | $7M | |
| R&D Expense | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | |
| SG&A Expense | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Operating Income | $-409.0K | $-522.0K | $-276.0K | $185.0K | $-527.0K | $-2M | $4M | $732.0K | $1M | $-272.0K | $-3M | $-2M | $-3M | $-3M | $-2M | $7.0K | |
| Other Non-op | $-6.0K | $27.0K | $39.0K | $70.0K | $75.0K | $42.0K | $19.0K | $7.0K | $5.0K | $81.0K | $58.0K | $-105.0K | $14.0K | $-20.0K | $36.0K | $-9.0K | |
| Pretax Income | $-415.0K | $-495.0K | $-237.0K | $255.0K | $-452.0K | $-2M | $5M | $739.0K | $1M | $-191.0K | $-3M | $-2M | $-3M | $-3M | $-2M | $-2.0K | |
| Income Tax | $11.0K | $172.0K | $42.0K | $18.0K | $14.0K | $-130.0K | $23.0K | $11.0K | $21.0K | $-82.0K | $11.0K | $11.0K | $28.0K | $20.0K | $17.0K | $14.0K | |
| Net Income | $-426.0K | $-728.0K | $-279.0K | $268.0K | $-466.0K | $-2M | $4M | $728.0K | $1M | $-109.0K | $-3M | $-2M | $-3M | $-3M | $-2M | $-16.0K | |
| EPS (Basic) | $-0.03 | $-0.05 | $-0.02 | $0.02 | $-0.03 | $-0.14 | $0.33 | $0.05 | $0.10 | $-0.01 | $-0.19 | $-0.15 | $-0.19 | $-0.19 | $-0.18 | $0.00 | |
| EPS (Diluted) | · | $-0.05 | $-0.02 | $0.02 | $-0.03 | $-0.12 | $0.31 | $0.05 | $0.09 | $-0.01 | $-0.19 | $-0.15 | $-0.19 | $-0.19 | $-0.18 | $0.00 | |
| Shares (Basic) | 13,897,535 | · | 13,886,797 | 13,791,913 | 13,788,414 | · | 13,700,627 | 13,593,766 | 13,593,766 | · | 13,593,758 | 13,497,061 | 13,506,782 | · | 13,558,642 | 13,528,643 | |
| Shares (Diluted) | · | · | 13,886,797 | 14,457,837 | 13,788,414 | · | 14,364,904 | 14,016,953 | 14,042,379 | · | 13,593,758 | 13,497,061 | 13,506,782 | · | 13,558,642 | 13,528,643 | |
| EBITDA | $-95.0K | · | $65.0K | $542.0K | $-169.0K | · | $5M | $1M | $2M | · | $-2M | $-1M | $-2M | · | $-2M | $567.0K |
Stato Patrimoniale
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $5M | $7M | $9M | $10M | $10M | $3M | $3M | $3M | $3M | $4M | $6M | $5M | $10M | $12M | $11M | |
| Receivables | $14M | $13M | $12M | $12M | $9M | $11M | $16M | $10M | $9M | $10M | $8M | $8M | $9M | $8M | $8M | $9M | |
| Prepaid Expense | $1M | $1M | $991.0K | $1M | $1M | $1M | $713.0K | $860.0K | $1M | $1M | $835.0K | $780.0K | $1M | $1M | $661.0K | $834.0K | |
| Current Assets | $19M | $19M | $20M | $21M | $21M | $22M | $20M | $14M | $13M | $14M | $13M | $14M | $15M | $19M | $20M | $21M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $8M | |
| PP&E (Gross) | $17M | $16M | $16M | $16M | $16M | $16M | $17M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $15M | $14M | |
| Accum. Depreciation | $13M | $13M | $12M | $12M | $12M | $12M | $12M | $11M | $11M | $10M | $10M | $9M | $9M | $9M | $7M | $7M | |
| Goodwill | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | |
| Other Non-current Assets | $201.0K | $212.0K | $196.0K | $196.0K | $196.0K | $196.0K | $185.0K | $185.0K | $185.0K | $185.0K | $185.0K | $185.0K | $184.0K | $15.0K | $15.0K | $15.0K | |
| Total Assets | $33M | $27M | $28M | $30M | $31M | $32M | $31M | $25M | $25M | $26M | $27M | $28M | $30M | $34M | $36M | $36M | |
| Accounts Payable | $6M | $7M | $6M | $6M | $5M | $4M | $5M | $5M | $5M | $6M | $5M | $5M | $6M | $5M | $4M | $5M | |
| Accrued Liabilities | $3M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Current Liabilities | $19M | $20M | $21M | $22M | $23M | $24M | $20M | $19M | $19M | $22M | $22M | $21M | $20M | $22M | $21M | $19M | |
| Capital Leases | $10M | $3M | $3M | $4M | $4M | $5M | $5M | $5M | $6M | $6M | $6M | $7M | $7M | $7M | $8M | $8M | |
| Other Non-current Liabilities | $215.0K | $7.0K | $27.0K | $46.0K | $66.0K | $85.0K | $285.0K | $324.0K | $363.0K | $401.0K | $439.0K | $476.0K | $514.0K | $551.0K | $588.0K | $624.0K | |
| Total Liabilities | $29M | $23M | $24M | $26M | $27M | $29M | $25M | $25M | $25M | $28M | $29M | $28M | $28M | $30M | $29M | $27M | |
| Common Stock | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | |
| Retained Earnings | $-81M | $-81M | $-80M | $-80M | $-80M | $-80M | $-78M | $-83M | $-83M | $-85M | $-84M | $-82M | $-80M | $-77M | $-75M | $-72M | |
| Treasury Stock | $708.0K | $708.0K | $708.0K | $708.0K | $708.0K | $708.0K | $708.0K | $708.0K | $708.0K | $708.0K | $708.0K | $708.0K | $676.0K | $74.0K | · | · | |
| Stockholders' Equity | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $681.0K | $-332.0K | $-2M | $-2M | $93.0K | $2M | $5M | $7M | $9M | |
| Liabilities + Equity | $33M | $27M | $28M | $30M | $31M | $32M | $31M | $25M | $25M | $26M | $27M | $28M | $30M | $34M | $36M | $36M | |
| Shares Outstanding | 13,918,569 | 13,886,826 | 13,886,826 | 13,886,326 | 13,788,421 | 13,777,170 | 13,705,570 | 13,698,903 | 13,593,766 | 13,593,766 | 13,593,766 | 13,593,766 | 13,484,110 | 13,544,228 | 13,558,650 | 13,558,650 |
Flusso di cassa
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $314.0K | $344.0K | $341.0K | $357.0K | $358.0K | $354.0K | $398.0K | $399.0K | $449.0K | $490.0K | $481.0K | $484.0K | $445.0K | $437.0K | $575.0K | $560.0K | |
| Stock-based Comp | $766.0K | $357.0K | $423.0K | $249.0K | $208.0K | $131.0K | $256.0K | $9.0K | $258.0K | $263.0K | $379.0K | $53.0K | $423.0K | $208.0K | $331.0K | $119.0K | |
| Other Non-cash | $-1M | · | · | · | $470.0K | · | · | · | $-2M | · | · | · | $-2M | · | · | · | |
| Operating Cash Flow | $-492.0K | $-2M | $-1M | $-2M | $600.0K | $7M | $490.0K | $-283.0K | $311.0K | $-2M | $-919.0K | $589.0K | $-4M | $-692.0K | $2M | $3M | |
| CapEx | $55.0K | $239.0K | $37.0K | $242.0K | $46.0K | $253.0K | $42.0K | $94.0K | $0 | $-3.0K | $18.0K | $79.0K | $668.0K | $760.0K | $754.0K | $604.0K | |
| Investing Cash Flow | $-55.0K | $-238.0K | $-14.0K | $-242.0K | $-46.0K | $-253.0K | $-42.0K | $-94.0K | $0 | $3.0K | $-18.0K | $-79.0K | $-668.0K | $-760.0K | $-754.0K | $-604.0K | |
| Stock Repurchased | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $32.0K | $602.0K | $74.0K | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $0 | · | · | · | $-602.0K | · | · | · | |
| Financing Cash Flow | $33.0K | $-19.0K | $-36.0K | $168.0K | $-14.0K | $-32.0K | $0 | $239.0K | $-37.0K | $-37.0K | $-108.0K | $134.0K | $-590.0K | $-75.0K | $0 | $86.0K | |
| Net Change in Cash | $-514.0K | $-2M | $-1M | $-2M | $540.0K | $7M | $448.0K | $-138.0K | $274.0K | $-2M | $-1M | $644.0K | $-5M | $-2M | $819.0K | $3M | |
| Free Cash Flow | $-547.0K | · | · | · | $554.0K | · | · | · | $311.0K | · | · | · | $-5M | · | · | · |
Redditività
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2.7% | · | -1.7% | 1.2% | -3.8% | · | 26.4% | 5.4% | 9.4% | · | -21.4% | -16.9% | -20.3% | · | -19.2% | 0.05% | |
| Net Margin | -2.8% | · | -1.7% | 1.8% | -3.1% | · | 26.4% | 5.4% | 9.3% | · | -21.1% | -17.9% | -20.4% | · | -19.1% | -0.11% | |
| Pretax Margin | -2.7% | · | -1.4% | 1.7% | -3.2% | · | 26.5% | 5.5% | 9.5% | · | -21.0% | -17.8% | -20.2% | · | -19.0% | -0.01% | |
| EBITDA Margin | -0.62% | · | 0.39% | 3.6% | -1.2% | · | 28.7% | 8.4% | 12.6% | · | -17.4% | -12.7% | -16.8% | · | -14.7% | 4.0% | |
| ROA | -1.3% | · | -0.94% | 0.97% | -1.6% | · | 15.7% | 2.7% | 4.8% | · | -8.0% | -6.4% | -8.0% | · | -7.0% | -0.05% | |
| ROE | -11.5% | · | -5.7% | 11.1% | -27.5% | · | 263.6% | 188.1% | 167.2% | · | -101.1% | -44.7% | -47.1% | · | -29.9% | -0.19% | |
| ROIC | -10.8% | · | -7.6% | 4.1% | -15.5% | · | 81.8% | 105.9% | -394.0% | · | 125.8% | -2113.4% | -135.6% | · | -35.0% | 0.61% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | · | 1.0 | 1.0 | 0.9 | · | 1.0 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 1.0 | 1.1 | |
| Quick Ratio | 1.0 | · | 0.9 | 0.9 | 0.9 | · | 1.0 | 0.7 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.9 | 1.1 |
Efficienza
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | |
| Receivables Turnover | 1.3 | · | 1.2 | 1.4 | 1.5 | · | 1.4 | 1.5 | 1.6 | · | 1.5 | 1.4 | 1.4 | · | 1.5 | 1.7 |
Per Azione
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.28 | · | $0.31 | $0.30 | $0.25 | · | $0.40 | $0.05 | $-0.02 | · | $-0.15 | $0.01 | $0.14 | · | $0.52 | $0.68 | |
| Revenue / Share | · | · | $1.19 | $1.04 | $1.01 | · | $1.19 | $0.96 | $1.00 | · | $0.88 | $0.86 | $0.93 | · | $0.94 | $1.06 | |
| Cash Flow / Share | · | · | · | · | $0.04 | · | · | · | $0.02 | · | · | · | $-0.30 | · | · | · | |
| Cash / Share | $0.31 | · | $0.51 | $0.61 | $0.75 | · | $0.23 | $0.20 | $0.21 | · | $0.33 | $0.41 | $0.36 | · | $0.86 | $0.80 | |
| EPS (TTM) | $-0.08 | · | $-0.15 | $0.18 | $0.21 | · | $0.44 | $-0.06 | $-0.26 | · | $-0.72 | $-0.71 | $-0.56 | · | $-0.22 | $0.01 |
Valutazione (TTM)
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $61M | · | $58M | $58M | $57M | · | $59M | $54M | $52M | · | $49M | $50M | $53M | · | $54M | $54M | |
| Net Income TTM | $-1M | · | $-2M | $2M | $3M | · | $6M | $-598.0K | $-3M | · | $-10M | $-10M | $-8M | · | $-3M | $108.0K | |
| Market Cap | $75M | · | $102M | $95M | $87M | · | $151M | $54M | $65M | · | $79M | $74M | $88M | · | $56M | $94M | |
| P/E | -67.0 | · | -48.7 | 37.9 | 30.1 | · | 25.0 | -65.2 | -18.4 | · | -8.1 | -7.7 | -11.6 | · | -18.7 | 694.0 | |
| P/S | 1.2 | · | 1.8 | 1.6 | 1.5 | · | 2.6 | 1.0 | 1.3 | · | 1.6 | 1.5 | 1.7 | · | 1.0 | 1.7 | |
| P/B | 19.2 | · | 23.7 | 22.7 | 24.8 | · | 27.5 | 78.7 | -196.1 | · | -38.4 | 798.1 | 46.1 | · | 7.9 | 10.3 | |
| P / Tangible Book | 21.0 | · | 25.7 | 24.7 | 27.5 | · | 29.3 | 154.8 | · | · | · | · | 55.9 | · | 8.3 | 10.6 | |
| P / Cash Flow | -151.6 | · | · | · | 145.2 | · | · | · | 209.4 | · | · | · | -22.0 | · | · | · | |
| Earnings Yield | -1.5% | · | -2.1% | 2.6% | 3.3% | · | 4.0% | -1.5% | -5.4% | · | -12.4% | -13.0% | -8.6% | · | -5.3% | 0.14% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|---|
| Ricavi | $59M | $57M | $50M | $54M | $49M |
| Margine Operativo % | -1.9% | 8.0% | -14.7% | -9.8% | 1.2% |
| Utile netto | $-1M | $5M | $-7M | $-5M | $548.0K |
| EPS Diluito | $-0.08 | $0.33 | $-0.54 | $-0.39 | $0.04 |
| Metrica | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|---|
| Rapporto corrente | 1.0 | 0.9 | 0.6 | 0.9 | 1.1 |
| Quick Ratio | 0.9 | 0.9 | 0.6 | 0.8 | 1.1 |
| Metrica | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-5M | $7M | $-7M | $1M | $4M |
Proprietari istituzionali (13F) 29 filer · $38.4M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
29
Valore detenuto
$38.4M
Nuove posizioni
4
Posizioni chiuse
2
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 4 (0 vs trimestre precedente) | 2 (-3 vs trimestre precedente) | 5 (0 vs trimestre precedente) | 7 (0 vs trimestre precedente) | +134K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| BATTERY MANAGEMENT CORP. | $14.917.506 | 2.421.673 | 38,86% | Azioni |
| NEA Management Company, LLC | $10.556.515 | 1.713.720 | 27,50% | Azioni |
| VANGUARD GROUP INC | $2.312.121 | 334.605 | 6,02% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.856.334 | 301.353 | 4,84% | Azioni |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $1.821.253 | 295.658 | 4,74% | Azioni |
| MORGAN STANLEY | $1.450.064 | 235.400 | 3,78% | Azioni |
| BANK OF AMERICA CORP /DE/ | $1.318.597 | 214.058 | 3,43% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $856.480 | 139.039 | 2,23% | Azioni |
| BlackRock, Inc. | $799.864 | 129.848 | 2,08% | Azioni |
| Mink Brook Asset Management LLC | $685.842 | 111.338 | 1,79% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $470.118 | 76.300 | 1,22% | Azioni |
| HighTower Advisors, LLC | $258.110 | 41.901 | 0,67% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $204.752 | 33.239 | 0,53% | Azioni |
| NORTHERN TRUST CORP | $171.926 | 27.910 | 0,45% | Azioni |
| STATE STREET CORP | $161.410 | 26.203 | 0,42% | Azioni |
| Bank of New York Mellon Corp | $133.142 | 21.614 | 0,35% | Azioni |
| CITADEL ADVISORS LLC | $112.697 | 18.295 | 0,29% | Azioni |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $112.241 | 18.221 | 0,29% | Azioni |
| Mesirow Financial Investment Management, Inc. | $97.328 | 15.800 | 0,25% | Azioni |
| MERCER GLOBAL ADVISORS INC /ADV | $78.694 | 12.775 | 0,20% | Azioni |
| Vanguard Global Advisers, LLC | $12.893 | 2.093 | 0,03% | Azioni |
| ACADIAN ASSET MANAGEMENT LLC | $125 | 20.523 | 0,00% | Azioni |
| BARCLAYS PLC | $80 | 13 | 0,00% | Azioni |
| Cambridge Investment Research Advisors, Inc. | $75 | 12.252 | 0,00% | Azioni |
| JPMORGAN CHASE & CO | $71 | 11 | 0,00% | Azioni |
| Cassaday & Co Wealth Management LLC | $62 | 10 | 0,00% | Azioni |
| SBI Securities Co., Ltd. | $25 | 4 | 0,00% | Azioni |
| FMR LLC | $5 | 1 | 0,00% | Azioni |
| Capital Advisors, Ltd. LLC | $0 | 48 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 9 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| New Enterprise Associates 14, L.P., NEA Partners 14, L.P., NEA 14 GP, LTD, Forest Baskett, Anthony A. Florence, Jr., Patrick J. Kerins, Mohamad Makhzoumi, Scott D. Sandell ×2 depositi | 06 Maggio 2024 | · | Deposito iniziale | · | SEC |
| Norman H. Pessin, Brian Pessin ×2 depositi | 08 Agosto 2017 | · | Deposito iniziale | Investimento passivo | SEC |
| PAR Investment Partners, L.P., PAR Group, L.P., PAR Capital Management, Inc., Arthur G. Epker, III ×4 depositi | 28 Ottobre 2016 | · | Deposito iniziale | · | SEC |
| Joel Ackerman ×2 depositi | 23 Marzo 2015 | · | Deposito iniziale | Investimento passivo | SEC |
| Ronnie Morris ×2 depositi | 23 Marzo 2015 | · | Deposito iniziale | Investimento passivo | SEC |
| Battery Ventures IX, L.P., Battery Investment Partners IX, LLC, Battery Partners IX, LLC, Battery Management Corp., Scott R. Tobin, Thomas J. Crotty, Richard D. Frisbie, Kenneth P Lawler, R. David Tabors, Roger H. Lee, Neeraj Agrawal, Michael M. Brown, Jesse Feldman ×4 depositi | 16 Marzo 2015 | · | Deposito iniziale | Investimento passivo | SEC |
| Persona segnalante non divulgata | 29 Maggio 2007 | · | Deposito iniziale | · | SEC |
| Manuel Hidalgo. | 18 Gennaio 2007 | · | Deposito iniziale | Investimento passivo | SEC |
| Persona segnalante non divulgata | 11 Gennaio 2007 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 18 insider · 7 dirigenti · 11 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Robert Lawrence Brainin | CEO | 16 Luglio 2025 A | · | 0 | 0 | $0 |
| Ronnie Morris | CEO | 17 Marzo 2023 P | 858.878 | 0 | 0 | $0 |
| CHAMPIONS SPORTS INC | Chairman, President and CEO | 11 Ottobre 2004 P | 9.548.000 | 0 | 0 | $0 |
| Mark Schonau | Accting PEO and CFO | 21 Luglio 2010 A | 8.526 | 0 | 0 | $0 |
| Brady Davis | President | 09 Ottobre 2023 A | · | 0 | 0 | $0 |
| Douglas D Burkett | President | 03 Ottobre 2008 P | · | 0 | 0 | $0 |
| David Barry Miller | Vice President, Finance | 21 Luglio 2016 D | · | 0 | 0 | $0 |
| Philip P. Breitfeld | Direttore | 05 Novembre 2025 A | 5.717 | 0 | 0 | $0 |
| Daniel Newman Mendelson | Direttore | 05 Novembre 2025 A | 198.625 | 0 | 0 | $0 |
| David Sidransky | Direttore | 05 Novembre 2025 A | 767.043 | 0 | 0 | $0 |
| Joel Ackerman | Direttore | 05 Novembre 2025 A | 1.056.539 | 0 | 0 | $0 |
| Scott R. Tobin | Direttore | 05 Novembre 2025 A | 30.000 | 0 | 0 | $0 |
| Abba David Poliakoff | Direttore | 19 Gennaio 2021 M | 81.274 | 0 | 0 | $0 |
| Arthur G Epker III | Direttore | 13 Ottobre 2014 A | · | 0 | 0 | $0 |
| Ana Stancic | Direttore | 14 Luglio 2011 A | · | 0 | 0 | $0 |
| Michael M. Brown | Proprietario del 10% | 28 Gennaio 2013 A | 16.031.040 | 0 | 0 | $0 |
| James Martell | · | 06 Gennaio 2012 G | 1.784.828 | 0 | 0 | $0 |
| Durwood Settles | · | 15 Gennaio 2007 A | · | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 3 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
CSBR Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 7 analisti
COMPRA
2 28,6%
Acquisto forte
4 57,1%
Compra
1 14,3%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| CSBR | $83M | -74.5 | 4.4% | -2.0% | -30.5% | · |
| NAUT | $247M | -4.1 | · | · | -34.9% | · |
| QTRX | $297M | -2.5 | 1.1% | -77.1% | -36.4% | 46.8% |
| CDXS | $147M | -3.3 | 18.6% | -62.5% | -82.8% | · |
| SEER | · | -1.4 | 17.0% | · | · | · |
| MXCT | $166M | -3.7 | -14.5% | -135.1% | -24.6% | 81.2% |
| HYFT | · | · | · | -89.7% | -78.9% | 58.8% |
| CIRC | · | · | · | · | · | · |
| RPID | · | -2.8 | 19.7% | -140.3% | -107.4% | · |
| HBIO | $30M | -0.5 | -8.1% | -65.5% | -384.8% | 57.7% |
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | · |
Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento
Nessun segnale aperto al momento — nessuna scheda è compilata, e questo è onesto.
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Set 11, 2026